Sensitivity of Angiotensin II Type II Receptors in Women Following Preeclampsia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Sensitivity of Angiotensin II Type II Receptors in Women Following Preeclampsia — Stella

Recruiting

Back to Preeclampsia Postpartum trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

United States

University of Iowa, Iowa City, Iowa

Key details

Phase

Very early testing

Sponsor

Anna Stanhewicz, PhD

Enrollment target

~30 participants

Started

June 2023

Primary completion

August 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 45 Years

Sex

Female only

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov